⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2462698 | 1.00 | — | — | |
| SCHEMBL14179775 | 1.00 | — | — | |
| SCHEMBL10210919 | 1.00 | — | — | |
| SCHEMBL14782740 | 1.00 | — | — | |
| SCHEMBL18464513 | 1.00 | — | — | |
| SCHEMBL15031196 | 1.00 | — | — | |
| SCHEMBL13271938 | 1.00 | — | — | |
| SCHEMBL3731733 | 1.00 | — | — | |
| SCHEMBL20702230 | 1.00 | — | — | |
| SCHEMBL1863374 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016142950-A1 | A NOVEL PROCESS FOR PREPARING (2S,3R,4R,5S,6R)-2-{3-[5-[4-FLUORO-PHENYL)- THIOPHEN-2-YLMETHYL]-4-METHYL-PHENYL}-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,4,5- TRIOL AND ITS STABLE AMORPHOUS HEMIHYDRATE FORM | HARMAN FINOCHEM LIMITED (IN) | 2016-09-15 | — | — | WO | claimed |
| EP-4739697-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zaklady Farmaceutyczne Polpharma S.A. (PL) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025008539-A1 | PROCESS FOR THE PREPARATION OF DAPAGLIFLOZIN | Zakłady Farmaceutyczne POLPHARMA S.A. (PL) | 2025-01-09 | — | — | WO | disclosed |
| CN-111233915-B | Preparation method of 2,3,4, 6-tetra-O-trimethylsilyl-D-glucolactone | 上海科胜药物研发有限公司 | 2023-09-22 | — | — | CN | disclosed |
| EP-4036100-A1 | SPIROKETAL DERIVATIVES AND PROCESS FOR PREPARATION OF SPIROKETAL DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2022-08-03 | — | — | EP | disclosed |
| EP-3170834-B1 | CRYSTALLINE FORMS OF (1S,3'R,4'S,5'S,6'R)-6-[(4-ETHYLPHENYL)METHYL]-3',4',5',6'-TETRAHYDRO-6'-(HYDROXYMETHYL)SPIRO[ISOBENZOFURAN-1(3H) 2'-[2H]PYRAN]-3',4',5'-TRIOL | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-11198703-B2 | Process for the preparation of SGLT2 inhibitors and intermediates thereof | Piramal Enterprises Limited (IN) | 2021-12-14 | — | — | US | disclosed |
| EP-2896397-B2 | Novel compounds having inhibitory activity against sodium-dependant glucose transporter | MITSUBISHI TANABE PHARMA CORP (JP) | 2020-10-07 | — | — | EP | disclosed |
| CN-111233915-A | Preparation method of 2,3,4, 6-tetra-O-trimethylsilyl-D-gluconolactone | 上海科胜药物研发有限公司 | 2020-06-05 | — | — | CN | disclosed |
| US-20200123186-A1 | A PROCESS FOR THE PREPARATION OF SGLT2 INHIBITORS AND INTERMEDIATES THEREOF | Piramal Enterprises Limited (IN) | 2020-04-23 | — | — | US | disclosed |
| US-20110306778-A1 | CRYSTAL OF SPIROKETAL DERIVATIVES AND PROCESS FOR PREPARATION OF SPIROKETAL DERIVATIVES | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2011-12-15 | — | — | US | disclosed |
| WO-2011107494-A1 | NOVEL AROMATIC GLYCOSIDE DERIVATIVES, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND THE USE THEREOF | SANOFI (FR) | 2011-09-09 | — | — | WO | disclosed |
| EP-2312944-A1 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE | Theracos, Inc. (US) | 2011-04-27 | — | — | EP | disclosed |
| EP-2308886-A1 | CRYSTAL OF SPIROKETAL DERIVATIVE, AND PROCESS FOR PRODUCTION THEREOF | Chugai Seiyaku Kabushiki Kaisha (JP) | 2011-04-13 | — | — | EP | disclosed |
| EP-2187742-A1 | BENZYLBENZENE DERIVATIVES AND METHODS OF USE | Theracos, Inc. (US) | 2010-05-26 | — | — | EP | disclosed |
| US-20100094025-A1 | METHOD FOR PRODUCING C-GLYCOSIDE DERIVATIVE AND INTERMEDIATE FOR SYNTHESIS THEREOF | ASTELLAS PHARMA INC. (JP) | 2010-04-15 | — | — | US | disclosed |
| US-20100094025-A1 | METHOD FOR PRODUCING C-GLYCOSIDE DERIVATIVE AND INTERMEDIATE FOR SYNTHESIS THEREOF | ASTELLAS PHARMA INC. (JP) | 2010-04-15 | — | — | US | disclosed |
| WO-2010009243-A1 | DEUTERATED BENZYLBENZENE DERIVATIVES AND METHODS OF USE | THERACOS, INC. (US) | 2010-01-21 | — | — | WO | disclosed |
| EP-2105442-A1 | METHOD FOR PRODUCING C-GLYCOSIDE DERIVATIVE AND SYNTHETIC INTERMEDIATE THEREOF | Astellas Pharma Inc. (JP) | 2009-09-30 | — | — | EP | disclosed |
| WO-2009026537-A1 | BENZYLBENZENE DERIVATIVES AND METHODS OF USE | THERACOS, INC. (US) | 2009-02-26 | — | — | WO | disclosed |